Unia Europejska -
polski -
EMA (European Medicines Agency)
pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - Środki przeciwnowotworowe - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
Unia Europejska -
polski -
EMA (European Medicines Agency)
alunbrig
takeda pharma a/s - brigatinib - rak, niedrobnokomórkowe płuca - Środki przeciwnowotworowe - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
Unia Europejska -
polski -
EMA (European Medicines Agency)
turalio
daiichi sankyo europe gmbh - pexidartinib - giant cell tumor of tendon sheath; synovitis, pigmented villonodular - Środki przeciwnowotworowe - treatment of tenosynovial giant cell tumour.
Polska -
polski -
URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)
orungal 100 mg kapsułki
janssen-cilag international n.v. - itraconazolum - kapsułki - 100 mg